Provided by Tiger Trade Technology Pte. Ltd.

Minerva Neurosciences

4.80
+0.580013.74%
Post-market: 4.800.00000.00%19:41 EST
Volume:78.07K
Turnover:367.72K
Market Cap:207.72M
PE:-2.59
High:4.92
Open:4.29
Low:4.13
Close:4.22
52wk High:12.46
52wk Low:1.15
Shares:43.27M
Float Shares:5.44M
Volume Ratio:0.74
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8533
EPS(LYR):0.1901
ROE:-675.09%
ROA:-25.82%
PB:-6.01
PE(LYR):25.25

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV) and Verastem (VSTM)

TIPRANKS
·
Feb 04

Minerva Neurosciences veröffentlicht Präsentation zu neuem Therapieansatz für Negativsymptome bei Schizophrenie

Reuters
·
Feb 04

Minerva Neurosciences kündigt virtuelle Expertenveranstaltung zu Phase-3-Studie mit Roluperidon an

Reuters
·
Feb 03

Minerva Neurosciences Hosts Virtual KOL Event on Roluperidone for Negative Symptoms of Schizophrenia

Reuters
·
Jan 26

Minerva Neurosciences Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 23, 2025

Minerva Neurosciences Expands Board Amid Fundraising Effort

TIPRANKS
·
Nov 19, 2025

BRIEF-Minerva Neurosciences Appoints Dr. Inderjit Kaul To The Company’S Board Of Directors

Reuters
·
Nov 19, 2025

Minerva Neurosciences Appoints Dr. Inderjit Kaul to Board of Directors

Reuters
·
Nov 19, 2025

Minerva Neurosciences Appoints DR. Inderjit Kaul to the Company’s Board of Directors

THOMSON REUTERS
·
Nov 19, 2025

Minerva Neurosciences Files Initial Beneficial Ownership Statement for Director Inderjit Kaul

Reuters
·
Nov 19, 2025

Minerva Neurosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Nov 15, 2025

Minerva Neurosciences Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 11, 2025

Minerva Neurosciences (NERV) Gets a Hold from H.C. Wainwright

TIPRANKS
·
Nov 10, 2025

Minerva Neurosciences Is Maintained at Neutral by HC Wainwright & Co.

Dow Jones
·
Nov 06, 2025

Minerva price target lowered to $4 from $5 at H.C. Wainwright

TIPRANKS
·
Nov 06, 2025

Minerva Neurosciences reports $2.7 mln Q3 net loss

Reuters
·
Nov 05, 2025

Minerva Neurosciences Q3 EPS $(0.36) Misses $(0.35) Estimate

Benzinga
·
Nov 05, 2025

BRIEF-Minerva Neurosciences Q3 Net Income USD -2.744 Million

Reuters
·
Nov 05, 2025

Minerva Neurosciences Secures $80 Million Financing and Plans Phase 3 Roluperidone Trial

Reuters
·
Nov 05, 2025

Minerva Neurosciences Q3 Operating Expenses USD 2.844 Million

THOMSON REUTERS
·
Nov 05, 2025